China vaccinates thousands before vaccination tests are completed

Corona infections exceed 5 million in India ... and the virus is spreading rapidly

Indians line up with masks as they celebrate Prime Minister Modi turning 70.

The new Corona virus is spreading very quickly in India, as the number of infections with it has exceeded the threshold of five million, while China is working to immunize tens of thousands of its citizens with experimental Corona virus vaccines before completing its tests.

In detail, the second largest country in the world in population recorded a million new infections within just 11 days, bringing the number of cases to 5.02 million.

India has become the second country most affected by the pandemic, after the United States, with 6.59 million infections.

Yesterday, the number of new infections exceeded 90,000, while 1,290 people died, which constitutes a record number, according to the Ministry of Health.

"People have given up any fear or are too tired to be careful," said New Delhi contractor Jayant Surana.

They want to go out and earn a living. ”

It took India 127 days to cross the one million mark, but the next million was recorded within 21 days, according to the Times of India, which is a much faster spread than that recorded in the United States and Brazil.

After barely 29 days, India has become the third country in the world to cross the 4 million mark, after the United States and Brazil.

The number of injuries reached more than four million on the fifth of September.

Two days later, India became the second country in the world in terms of injuries, after the United States.

India, with a population of 1.3 billion people, performs about one million examinations daily, which is insufficient according to many experts.

Experts believe that the actual number of injuries may be much higher.

Studies conducted in recent weeks confirmed this hypothesis, after residents in the two major cities of New Delhi and Mumbai were subjected to tests to detect the presence of antibodies to the virus.

The Indian Council of Medical Research, which coordinates the government response to the crisis, confirmed last week that its study leads to the assumption that 6.5 million people have been infected as of last May.

As of yesterday, the total deaths reached 82,066, which is half the number of deaths that were recorded in the United States (195 thousand), as many of these cases are not accurately recorded by the authorities even in normal times.

The public health sector in India suffers from a significant shortage of funding, and the country is home to some of the most populous cities in the year.

The government of Indian Prime Minister Narendra Modi imposed at the end of March a lockdown that was considered one of the strictest in the world in an attempt to curb the spread of the "Covid-19" epidemic.

Overnight, tens of millions of people lost their jobs.

Movement was prevented, shops and factories closed, and millions of displaced workers returned to cities, to their hometowns.

Experts estimate that this has led to the transmission of the virus from large cities to small ones.

India's GDP fell by nearly 24% between April and June in the first quarter of its new fiscal year, marking one of the biggest declines among global economic powers.

The closure gradually eased despite the new rise in injuries.

Some classes will open in schools from Monday, in addition to the Taj Mahal, India's main tourist teacher.

The official in charge of the Indian Public Health Foundation, a non-governmental organization K.

Srinath Reddy: "In the beginning there was strict isolation, and then some laxity until it was lifted completely."

"This sent the wrong message to the population, who thought that we might be able to control the situation and that the economy is the most important thing now," he added.

The virus is infecting more people and is spreading deep into small cities.

This comes at a time when China is working to immunize tens of thousands of its citizens with experimental Corona vaccines, and to attract international interest in developing these vaccines, despite the concern that experts feel about the safety of drugs that have not completed their regular tests.

China launched an exceptional vaccines program last July, through which it launched three experimental drugs developed by a unit of the state-owned giant, Sinopharma, and the US-listed Sinovac Biotech company.

A fourth vaccine for "Covid-19" disease caused by infection with the virus, developed by "Cansino Biology", was approved by the Chinese army for its use in June.

The immunization efforts aim to protect essential workers and reduce the chances of the virus returning to spread, and has also attracted attention in the context of the relentless efforts made by governments around the world to secure supplies of vaccines, and may lead to reshaping the Chinese role in the pandemic.

Beijing has not released official data on immunization in local target groups, which include workers in the medical sector, transport and food markets.

However, the Chinese national group, Biotec, affiliated to Sinopharm, which is developing two exceptionally used vaccines, and the company, Sinovac, confirmed that tens of thousands of people have been immunized at least.

The group "Biotech" said it produced hundreds of thousands of doses, as one of the vaccines needs to be immunized with two or three doses.

And Beijing launched an advertising campaign to approve experimental vaccines and spread community support for them, starting with the leaderships, as among the first to be immunized were the chief executives of "Sinovac" and "Sinopharm" and the head of research in the army.

The chief biosafety expert with the Chinese Center for Disease Prevention revealed this week that she received the vaccine in April, and announced that at least some vaccines will be ready for public use in early November.

The Chinese approach contradicts the approach of many Western countries, as experts warned against approving the exceptional use of vaccines whose trials have not yet been completed, based on the lack of information on their effectiveness and potential side effects in the long term.

The safety of vaccines came to light last week, when the company, "AstraZeneca", stopped clinical trials in its final stages on a vaccine for "Covid-19".

The company resumed testing over the weekend after receiving the green light from the relevant authorities.

Vice President of the "Biotech" group, Zhang Yuntao, told "Reuters" that his company had found interest in foreign countries to buy about 500 million doses of its experimental vaccine.

• A fourth vaccine developed by the company "Cansino Biology" that gets approval from the Chinese army for use in June.

• The public health sector in India suffers from a severe shortage of funding, while this country includes some of the most populous cities in the year.

Follow our latest local and sports news, and the latest political and economic developments via Google news